Back to Browse Journals » Clinical Epidemiology » Volume 2

Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer

Authors Paul J Fitzgerald

Published 24 December 2009 Volume 2010:2 Pages 1—3


Review by Single-blind

Peer reviewer comments 3

Paul J Fitzgerald

The Zanvyl Krieger Mind/Brain Institute, Solomon H. Snyder, Department of Neuroscience, Johns Hopkins University, Baltimore, MD, USA

Abstract: Recently, I put forth the hypothesis that the signaling molecule, norepinephrine (NE), is an etiological factor in a number of types of cancer. In this brief commentary, I summarize evidence that NE plays a role in cancer and describe details involved in testing the hypothesis in humans through epidemiological investigation of existing medical records of persons who have taken pharmaceutical drugs that affect NE. If NE plays an etiological role in cancers of a number of organs, then taking a single pharmaceutical drug (such as clonidine, prazosin, or propranolol) that weakens NE signaling systemically, may simultaneously prevent or treat many different types of cancer, and this may represent a breakthrough in pharmaceutical prevention and possibly treatment of cancer.

Keywords: norepinephrine, acetylcholine, cancer, clonidine, prazosin, propranolol

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint

Fitzgerald PJ

Clinical Epidemiology 2012, 4:151-156

Published Date: 29 June 2012

Readers of this article also read:

Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder

Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J

Neuropsychiatric Disease and Treatment 2014, 10:243-248

Published Date: 3 February 2014

Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer

Wu Q, Shi Y, Chen L, Xiao XY, Dai GH

OncoTargets and Therapy 2013, 6:485-490

Published Date: 30 April 2013

Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study

Song X, Jiang Y, Ren CJ, Sun X, Zhang Q, Gong T, Zhang ZR

International Journal of Nanomedicine 2012, 7:3689-3699

Published Date: 13 July 2012

Newer agents for Helicobacter pylori eradication

Fiorini G, Zullo A, Gatta L, Castelli V, Ricci C, Cassol F, Vaira D

Clinical and Experimental Gastroenterology 2012, 5:109-112

Published Date: 18 June 2012

Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy

Sharif A Issa, Alan Connor, Maged Habib, et al

Clinical Ophthalmology 2011, 5:109-114

Published Date: 20 January 2011

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010

Mirtogenol® potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects

Robert D Steigerwalt Jr, Gianni Belcaro, Paolo Morazzoni, et al

Clinical Ophthalmology 2010, 4:471-476

Published Date: 12 May 2010

Tissue engineering scaffold material of porous nanohydroxyapatite/polyamide 66

Qian Xu, Hongyan Lu, Jingchao Zhang, et al

International Journal of Nanomedicine 2010, 5:331-335

Published Date: 20 April 2010